Form 10-K Sunshine Biopharma, Inc For: Dec 31 - StreetInsider.com

Liquidity and Capital ResourcesAs of December 31, 2020, we had cash and cash equivalents of $989,888.

We also used cash for operations of $657,299 and $495,798 for the years ended December 31, 2020 and 2019, respectively.

Net cash used in operating activities was $657,299 during our fiscal year ended December 31, 2020, compared to $495,798 during our fiscal year ended December 31, 2019.

As of December 31, 2020, the Company has received a total of $1,350,000 in funding under this agreement.

The Company had a cash balance of $989,888 and $40,501 as of December 31, 2020 and December 31, 2019, respectively.

Published On: Tue, 30 Mar 2021 19:25:07 GMT